The net result is maintained or improved glucose homeostasis, while the energy expenditure and lipolytic benefits of glucagon receptor activation are preserved [3]
Microdosing typically refers to taking subtherapeutic doses (smaller doses than the usual recommendations) of a drug to achieve benefits while minimizing side effects
Not sure if its just propaganda, but about bp157 google search says, BPC-157 affects the heart primarily by interacting with the nitric oxide (NO) system and blood vessel pathways, showing potential cardioprotective, blood pressure-modulating, and anti-arrhythmic effects in early research. Thats the kind of stuff that seriously plagues a lot of people, including endurance athletes
This legal requirement applies to all GLP-1 drugs, whether branded (Ozempic, Wegovy, Mounjaro) or compounded formulations
Celebrate Socially, Responsibly Whether youre on Mounjaro or Wegovy, maintaining balance is key
Active GLP-1 then flows to peripheral organs where it stimulates the incretin effect 1,2,10